Circulating CD5+ B-cell levels in 15 patients with rheumatoid arthritis (RA) not receiving remittive therapy was significantly increased when compared to 17 normal controls (mean +/- SE: RA, 19.7 +/- 2.85%; controls, 11.6 +/- 1.67%; P less than 0.02). In contrast, 24 patients with RA receiving gold
Expression of CD22 on peripheral B cells in patients with rheumatoid arthritis: relation to CD5-positive B cells
β Scribed by Yutaka Nakiri; Kentarou Minowa; Jun Suzuki; Akiko Mitsuo; Hirofumi Amano; Shinji Morimoto; Yoshiaki Tokano; Yoshinari Takasaki
- Publisher
- Springer
- Year
- 2007
- Tongue
- English
- Weight
- 102 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
CD5 (OKT1, Leu-1) is an antigen originally associated only with T cells. This antigen has recently been detected on a population of B cells that have been implicated in autoimmune diseases, particularly in rheumatoid arthritis (RA). We determined the percentage of these cells in the peripheral blood
## Abstract ## Objective To study the quantitative and phenotypic reconstitution of peripheral blood B cells and its relationship to the dynamics of clinical response in patients with rheumatoid arthritis (RA) following B cell depletion with rituximab. ## Methods Twentyβfour patients with active
Objective. B lymphocytes accumulate in the inflamed joints of patients with rheumatoid arthritis (RA) and are responsible for production of high amounts of (auto)-antibodies. The aim of this study was to determine the capacity of fibroblast-like synoviocytes (FLS) to contribute to the accumulation o